If you or a loved one were diagnosed with cancer after taking Zantac (Ranitidine), you may be entitled to recover compensation from a Zantac cancer lawsuit case or settlement claim.
A team of drug injury lawyers and class action attorneys is investigating potential Zantac lawsuit and settlement cases of individuals who were diagnosed with cancer after taking Zantac.
Zantac (known generically as Ranitidine) is an antacid and antihistimine medication used to treat heartburn, stomach ulcers, gastroesophageal reflux disease (GERD) and similiar conditions that cause too much stomach acid. Ranitidine is an H2 (histamine-2) blocker that decreases the amount of acid created in the stomach.
In September of 2019, the FDA issued a statement alerting the public that some ranitidine medicines, including some products known as the brand-name drug Zantac, contained a nitrosamine impurity called N-nitrosodimethylamine or NDMA. Thereafter, on April 1, 2020, the FDA requested that Zantac (ranitidine) be removed from the market.
Previously, Zantac and Ranitidine were the subject of various recalls due to the possible detection of NDMA, which has been called a probable human carcinogen (i.e., a substance that could cause cancer).
Zantac Cancer Lawsuit Cases
Zantac lawsuit and settlement cases potentially being investigated include claims of individuals who took Zantac and, within the past two (2) years, were diagnosed with cancer including, the following:
- Bladder cancer
- Breast cancer
- Colon cancer
- Esophageal cancer
- Gastric cancer
- Kidney cancer
- Liver cancer
- Lung cancer
- Pancreatic cancer
- Prostate cancer
- Stomach cancer
- Pancreatic adenocarcinoma
- Hepatocellular carcinoma
- Hepatoma
- Angiosarcoma of the liver
- Urothelial carcinoma
- Transitional cell carcinoma
- Invasive ductal carcinoma (IDC)
- Rectal or colon adenocarcinoma
Zantac cancer lawsuits filed in federal district courts were consolidated and/or transferred into a multi-district litigation or MDL, styled In Re Zantac (Ranitidine) Products Liability Litigation, MDL Case No. 2924, U.S. District Court, Southern District of Florida. Zantac cases were also filed in various state courts throughout the country, including in Delaware, Pennsylvania, California and Illinois.
Zantac Lawsuit & Settlement Updates
Recent updates about Zantac lawsuits and settlements include:
- May 2024: On May 8, 2024, it was reported that Pfizer had agreed to settle about 10,000 Zantac lawsuit cases pending in various state courts across the country. On May 28, 2024 a jury in Cook County Illinois found in favor of defendants in the first Zantac case to go to trial. On May 31, 2024, the Judge in the Delaware state court Zantac litigation ruled in favor of plaintiffs and denied Defendants Daubert motion, allowing plaintiffs’ Zantac injury claims to proceed.
- April 2024: On April 4, 2024 it was reported that Sanofi had settled about 4,000 Zantac lawsuits pending in certain state courts.
- February 2024: It was reported that GlaxoSmithKline had settled several Zantac lawsuits that were scheduled for trial.
- October 2023: Another state court Zantac case set for trial was settled. The details of this latest settlement are confidential.
Older Zantac Lawsuit and Settlement Updates
- August 2023: On August 14, 2023, certain plaintiffs filed an appeal with the United States Court of Appeals for the Eleventh Circuit regarding the Courts’ Daubert and summary judgment orders.
- January 2023: The Court in Delaware state court held Daubert hearings regarding Plaintiffs’ experts. There are almost 75,000 Zantac cases pending in Delaware state court
- December 2022: On December 6, 2022, the Judge overseeing the federal Zantac MDL granted Defendants’ Daubert motion to exclude Plaintiffs’ expert opinions on causation and granted Defendants’ motion for summary judgment. About 50,000 claims were pending in the federal MDL at the time. On December 25, 2022 Pfizer and Sanofi settled a case in California stated court that was set for trial.
Zantac Brands
Common brands of Zantac include, among others:
- Zantac
- Zantac 150
- Zantac 150 Maximum Strength
- Zantac Maximum Strength Cool Mint
- Zantac 75
- Zantac 75 Regular Strength
- Zantac Maximum Strength 150 Cool Mint
- Zantac Cool Mint
- Zantac Injection
If you or someone you love took Zantac (Ranitidine) for heartburn and were diagnosed with cancer, you may be entitled to compensation from a Zantac cancer lawsuit case or settlement claim. Contact a drug injury lawyer to request a free case review.
*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.
**The listing of a company (e.g., Sandoz, Pfizer, GlaxoSmithKline, Sanofi, Apotex, Perrigo, Lannett or Novitium) or product (e.g., Zantac or Ranitidine) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.
***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.
Fill out the form for a free attorney review.